MiMedx Group Statistics
Total Valuation
MiMedx Group has a market cap or net worth of $1.11 billion. The enterprise value is $1.03 billion.
| Market Cap | 1.11B |
| Enterprise Value | 1.03B |
Important Dates
The next estimated earnings date is Tuesday, April 29, 2025, after market close.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MiMedx Group has 147.37 million shares outstanding. The number of shares has increased by 2.12% in one year.
| Current Share Class | 147.37M |
| Shares Outstanding | 147.37M |
| Shares Change (YoY) | +2.12% |
| Shares Change (QoQ) | +0.59% |
| Owned by Insiders (%) | 1.64% |
| Owned by Institutions (%) | 44.62% |
| Float | 109.14M |
Valuation Ratios
The trailing PE ratio is 26.93 and the forward PE ratio is 27.93.
| PE Ratio | 26.93 |
| Forward PE | 27.93 |
| PS Ratio | 3.18 |
| Forward PS | 2.89 |
| PB Ratio | 5.74 |
| P/TBV Ratio | 6.86 |
| P/FCF Ratio | 17.22 |
| P/OCF Ratio | 16.79 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.78, with an EV/FCF ratio of 15.99.
| EV / Earnings | 24.32 |
| EV / Sales | 2.96 |
| EV / EBITDA | 15.78 |
| EV / EBIT | 17.39 |
| EV / FCF | 15.99 |
Financial Position
The company has a current ratio of 4.21, with a Debt / Equity ratio of 0.13.
| Current Ratio | 4.21 |
| Quick Ratio | 3.51 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.37 |
| Debt / FCF | 0.39 |
| Interest Coverage | 15.06 |
Financial Efficiency
Return on equity (ROE) is 25.01% and return on invested capital (ROIC) is 17.99%.
| Return on Equity (ROE) | 25.01% |
| Return on Assets (ROA) | 14.74% |
| Return on Invested Capital (ROIC) | 17.99% |
| Return on Capital Employed (ROCE) | 27.17% |
| Revenue Per Employee | $416,821 |
| Profits Per Employee | $50,680 |
| Employee Count | 837 |
| Asset Turnover | 1.39 |
| Inventory Turnover | 2.68 |
Taxes
In the past 12 months, MiMedx Group has paid $15.30 million in taxes.
| Income Tax | 15.30M |
| Effective Tax Rate | 26.70% |
Stock Price Statistics
The stock price has decreased by -0.92% in the last 52 weeks. The beta is 1.97, so MiMedx Group's price volatility has been higher than the market average.
| Beta (5Y) | 1.97 |
| 52-Week Price Change | -0.92% |
| 50-Day Moving Average | 8.28 |
| 200-Day Moving Average | 7.53 |
| Relative Strength Index (RSI) | 36.96 |
| Average Volume (20 Days) | 580,442 |
Short Selling Information
The latest short interest is 3.72 million, so 2.52% of the outstanding shares have been sold short.
| Short Interest | 3.72M |
| Short Previous Month | 3.87M |
| Short % of Shares Out | 2.52% |
| Short % of Float | 3.41% |
| Short Ratio (days to cover) | 6.72 |
Income Statement
In the last 12 months, MiMedx Group had revenue of $348.88 million and earned $42.42 million in profits. Earnings per share was $0.28.
| Revenue | 348.88M |
| Gross Profit | 288.81M |
| Operating Income | 59.31M |
| Pretax Income | 63.47M |
| Net Income | 42.42M |
| EBITDA | 65.35M |
| EBIT | 59.31M |
| Earnings Per Share (EPS) | $0.28 |
Balance Sheet
The company has $104.42 million in cash and $24.84 million in debt, giving a net cash position of $79.57 million or $0.54 per share.
| Cash & Cash Equivalents | 104.42M |
| Total Debt | 24.84M |
| Net Cash | 79.57M |
| Net Cash Per Share | $0.54 |
| Equity (Book Value) | 193.11M |
| Book Value Per Share | 1.31 |
| Working Capital | 146.29M |
Cash Flow
In the last 12 months, operating cash flow was $66.20 million and capital expenditures -$1.68 million, giving a free cash flow of $64.51 million.
| Operating Cash Flow | 66.20M |
| Capital Expenditures | -1.68M |
| Free Cash Flow | 64.51M |
| FCF Per Share | $0.44 |
Margins
Gross margin is 82.78%, with operating and profit margins of 17.00% and 12.16%.
| Gross Margin | 82.78% |
| Operating Margin | 17.00% |
| Pretax Margin | 16.42% |
| Profit Margin | 12.16% |
| EBITDA Margin | 18.73% |
| EBIT Margin | 17.00% |
| FCF Margin | 18.49% |
Dividends & Yields
MiMedx Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.12% |
| Shareholder Yield | -2.12% |
| Earnings Yield | 3.82% |
| FCF Yield | 5.81% |
Analyst Forecast
The average price target for MiMedx Group is $12.00, which is 59.15% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 59.15% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MiMedx Group has an Altman Z-Score of 11.1 and a Piotroski F-Score of 6.
| Altman Z-Score | 11.1 |
| Piotroski F-Score | 6 |